GLYC
Companies
NASDAQ
GlycoMimetics Inc.
Health Care
$13.27
-$11.63 (-46.71%)
Price Chart
Overview
About GLYC
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Market Cap
$16.6M
Volume
4.2M
Avg. Volume
5.7M
P/E Ratio
-2.9077778
Dividend Yield
0.00%
Employees
44.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.04
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, GLYC shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$16.6M
Volume4.2M
P/E Ratio-2.91
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 15, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025